Magenta Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $80,902,000.
Profit Margin
| 2016 | 0 | -9.43M | |
|---|---|---|---|
| 2017 | 0 | -35.49M | |
| 2018 | 0 | -57.51M | |
| 2019 | 0 | -68.72M | |
| 2020 | 0 | -69.19M | |
| 2021 | 0 | -65.56M | |
| 2022 | 0 | -72.02M |
MGTA Income Statement (2016 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||||
Research and development | 55.14M | 46.76M | 50.61M | 59.20M | 41.34M | 27.89M | 5.78M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 80.90M | 74.69M | 78.70M | 82.96M | 59.96M | 35.72M | 9.26M |
Operating income | -80.90M | -74.69M | -78.70M | -82.96M | -59.96M | -35.72M | -9.26M |
Other income (expenses), net | 4.44M | 3.55M | 3.76M | 6.2M | 2.44M | 236K | -163K |
Income before tax | -76.46M | -71.13M | -74.93M | -76.76M | -57.51M | -35.49M | -9.43M |
Income tax expense | -4.44M | -5.57M | -5.74M | -8.04M | 2.44M | 236K | 0 |
Net income | -72.02M | -65.56M | -69.19M | -68.72M | -57.51M | -35.49M | -9.43M |
Earnings per share | |||||||
Basic EPS | -23.05 | -22.67 | -29.93 | -35.28 | -59.42 | -1.65 | -0.44 |
Diluted EPS | -23.05 | -22.67 | -29.93 | -35.28 | -59.42 | -1.65 | -0.44 |
| Data source | Data source | Data source | Data source | Data source |